Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107155 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Effects of a Weight Management Program on Body Weight
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT04107155: Completed NA study, sponsored by Supplement Formulators.
NCT04107155 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04107155, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the safety and effectiveness of the Weight Management Program on body weight
Primary Outcome
Mean change from baseline to Day 60 in pounds from the Body Composition Analyzer
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Weight Management Formulation
- OTHER Handout with Suggestions for Healthy Eating and Overall Health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-07-23 |
| Est. Completion | 2019-12-20 |
| Phase | NA |
What the finished NCT04107155 record still lists
NCT04107155 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04107155 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04107155 about?
NCT04107155 is a clinical study titled "Study to Evaluate the Effects of a Weight Management Program on Body Weight". The purpose of the study is to assess the safety and effectiveness of the Weight Management Program on body weight
What is the current status of trial NCT04107155?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2019-07-23. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT04107155?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Weight Management Formulation (DIETARY_SUPPLEMENT), Handout with Suggestions for Healthy Eating and Overall Health (OTHER).
Who is sponsoring clinical trial NCT04107155?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04107155's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI